Microchimerism in children with rheumatic disorders: what does it mean?

Area of Science:

• Immunology
• Genetics
• Perinatology

Background:

• Bidirectional cell trafficking between mother and fetus during pregnancy leads to chimerism.
• Microchimerism, the persistence of low levels of non-self cells, is a known phenomenon.
• Maternal microchimerism has been detected in children and healthy adults years after birth.

Purpose of the Study:

• To investigate the persistence and levels of maternal microchimerism.
• To explore the association between maternal microchimerism and juvenile inflammatory myositis.
• To examine the potential role of human leukocyte antigen genes in microchimerism.

Main Methods:

• Longitudinal studies tracking cell persistence.
• Quantitative analysis of microchimeric cell levels.
• Genetic analysis of human leukocyte antigen (HLA) genes in mother-child pairs.

Main Results:

• Maternal microchimerism persists for many years post-birth in both mothers and children.
• Elevated levels of maternal microchimerism were observed in children diagnosed with juvenile dermatomyositis and juvenile idiopathic inflammatory myositis.
• The persistence and levels of microchimerism appear associated with the human leukocyte antigen (HLA) genes of both the offspring and the mother.

Conclusions:

• Maternal microchimerism is a long-term consequence of pregnancy.
• Increased maternal microchimerism in juvenile inflammatory myositis suggests a potential role in disease pathogenesis.
• Genetic factors, specifically HLA compatibility, may influence the dynamics of fetal-maternal cell trafficking and persistence.